![](/img/cover-not-exists.png)
Phase II study of continuous daily sunitinib dosing in patients with previously treated advanced non-small cell lung cancer
Novello, S, Scagliotti, G V, Rosell, R, Socinski, M A, Brahmer, J, Atkins, J, Pallares, C, Burgess, R, Tye, L, Selaru, PVolume:
101
Year:
2009
Language:
english
Pages:
6
DOI:
10.1038/sj.bjc.6605346
File:
PDF, 304 KB
english, 2009